End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.

The latest research study released by Market IntelliX evaluates market size and forecasts of End Stage Renal Disease (ESRD) Therapy in Global, including the following market information:

Global End Stage Renal Disease (ESRD) Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global End Stage Renal Disease (ESRD) Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemodialysis Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of End Stage Renal Disease (ESRD) Therapy include Fresenius, DaVita, Baxter, Nipro, B. Braun, Asahi Kasei, Nikkiso, WEGO and Newsol, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the End Stage Renal Disease (ESRD) Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global End Stage Renal Disease (ESRD) Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global End Stage Renal Disease (ESRD) Therapy Market Segment Percentages, by Type, 2021 (%)

Hemodialysis

Peritoneal Dialysis

Kidney Transplantation

Global End Stage Renal Disease (ESRD) Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global End Stage Renal Disease (ESRD) Therapy Market Segment Percentages, by Application, 2021 (%)

Hospitals

Kidney Dialysis Centers

At Homes

Others

Global End Stage Renal Disease (ESRD) Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global End Stage Renal Disease (ESRD) Therapy Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies End Stage Renal Disease (ESRD) Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies End Stage Renal Disease (ESRD) Therapy revenues share in global market, 2021 (%)

The report presents profiles of competitors in the market, Some of the prominent key players covered:

Fresenius

DaVita

Baxter

Nipro

B. Braun

Asahi Kasei

Nikkiso

WEGO

Newsol

Mayo Clinic

Guangdong Biolight

Medtronic

Sanxin Medtec

Jafron Biomedical

SWS Hemodialysis Care

Tianyi Medical

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 End Stage Renal Disease (ESRD) Therapy Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global End Stage Renal Disease (ESRD) Therapy Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global End Stage Renal Disease (ESRD) Therapy Overall Market Size

2.1 Global End Stage Renal Disease (ESRD) Therapy Market Size: 2021 VS 2028

2.2 Global End Stage Renal Disease (ESRD) Therapy Market Size, Prospects & Forecasts: 2017-2028

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top End Stage Renal Disease (ESRD) Therapy Players in Global Market

3.2 Top Global End Stage Renal Disease (ESRD) Therapy Companies Ranked by Revenue

3.3 Global End Stage Renal Disease (ESRD) Therapy Revenue by Companies

3.4 Top 3 and Top 5 End Stage Renal Disease (ESRD) Therapy Companies in Global Market, by Revenue in 2021

3.5 Global Companies End Stage Renal Disease (ESRD) Therapy Product Type

3.6 Tier 1, Tier 2 and Tier 3 End Stage Renal Disease (ESRD) Therapy Players in Global Market

3.6.1 List of Global Tier 1 End Stage Renal Disease (ESRD) Therapy Companies

3.6.2 List of Global Tier 2 and Tier 3 End Stage Renal Disease (ESRD) Therapy Companies

4 Market Sights by Product

4.1 Overview

4.1.1 by Type - Global End Stage Renal Disease (ESRD) Therapy Market Size Markets, 2021 & 2028

4.1.2 Hemodialysis

4.1.3 Peritoneal Dialysis

4.1.4 Kidney Transplantation

4.2 By Type - Global End Stage Renal Disease (ESRD) Therapy Revenue & Forecasts

4.2.1 By Type - Global End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2022

4.2.2 By Type - Global End Stage Renal Disease (ESRD) Therapy Revenue, 2023-2028

4.2.3 By Type - Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

5 Sights by Application

5.1 Overview

5.1.1 By Application - Global End Stage Renal Disease (ESRD) Therapy Market Size, 2021 & 2028

5.1.2 Hospitals

5.1.3 Kidney Dialysis Centers

5.1.4 At Homes

5.1.5 Others

5.2 By Application - Global End Stage Renal Disease (ESRD) Therapy Revenue & Forecasts

5.2.1 By Application - Global End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2022

5.2.2 By Application - Global End Stage Renal Disease (ESRD) Therapy Revenue, 2023-2028

5.2.3 By Application - Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

6 Sights by Region

6.1 By Region - Global End Stage Renal Disease (ESRD) Therapy Market Size, 2021 & 2028

6.2 By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue & Forecasts

6.2.1 By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2022

6.2.2 By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue, 2023-2028

6.2.3 By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

6.3 North America

6.3.1 By Country - North America End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2028

6.3.2 US End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.3.3 Canada End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.3.4 Mexico End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4 Europe

6.4.1 By Country - Europe End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2028

6.4.2 Germany End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4.3 France End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4.4 U.K. End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4.5 Italy End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4.6 Russia End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4.7 Nordic Countries End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.4.8 Benelux End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.5 Asia

6.5.1 By Region - Asia End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2028

6.5.2 China End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.5.3 Japan End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.5.4 South Korea End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.5.5 Southeast Asia End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.5.6 India End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.6 South America

6.6.1 By Country - South America End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2028

6.6.2 Brazil End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.6.3 Argentina End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.7 Middle East & Africa

6.7.1 By Country - Middle East & Africa End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2028

6.7.2 Turkey End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.7.3 Israel End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.7.4 Saudi Arabia End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

6.7.5 UAE End Stage Renal Disease (ESRD) Therapy Market Size, 2017-2028

7 Players Profiles

7.1 Fresenius

7.1.1 Fresenius Corporate Summary

7.1.2 Fresenius Business Overview

7.1.3 Fresenius End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.1.4 Fresenius End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.1.5 Fresenius Key News

7.2 DaVita

7.2.1 DaVita Corporate Summary

7.2.2 DaVita Business Overview

7.2.3 DaVita End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.2.4 DaVita End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.2.5 DaVita Key News

7.3 Baxter

7.3.1 Baxter Corporate Summary

7.3.2 Baxter Business Overview

7.3.3 Baxter End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.3.4 Baxter End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.3.5 Baxter Key News

7.4 Nipro

7.4.1 Nipro Corporate Summary

7.4.2 Nipro Business Overview

7.4.3 Nipro End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.4.4 Nipro End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.4.5 Nipro Key News

7.5 B. Braun

7.5.1 B. Braun Corporate Summary

7.5.2 B. Braun Business Overview

7.5.3 B. Braun End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.5.4 B. Braun End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.5.5 B. Braun Key News

7.6 Asahi Kasei

7.6.1 Asahi Kasei Corporate Summary

7.6.2 Asahi Kasei Business Overview

7.6.3 Asahi Kasei End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.6.4 Asahi Kasei End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.6.5 Asahi Kasei Key News

7.7 Nikkiso

7.7.1 Nikkiso Corporate Summary

7.7.2 Nikkiso Business Overview

7.7.3 Nikkiso End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.7.4 Nikkiso End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.7.5 Nikkiso Key News

7.8 WEGO

7.8.1 WEGO Corporate Summary

7.8.2 WEGO Business Overview

7.8.3 WEGO End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.8.4 WEGO End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.8.5 WEGO Key News

7.9 Newsol

7.9.1 Newsol Corporate Summary

7.9.2 Newsol Business Overview

7.9.3 Newsol End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.9.4 Newsol End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.9.5 Newsol Key News

7.10 Mayo Clinic

7.10.1 Mayo Clinic Corporate Summary

7.10.2 Mayo Clinic Business Overview

7.10.3 Mayo Clinic End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.10.4 Mayo Clinic End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.10.5 Mayo Clinic Key News

7.11 Guangdong Biolight

7.11.1 Guangdong Biolight Corporate Summary

7.11.2 Guangdong Biolight Business Overview

7.11.3 Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.11.4 Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.11.5 Guangdong Biolight Key News

7.12 Medtronic

7.12.1 Medtronic Corporate Summary

7.12.2 Medtronic Business Overview

7.12.3 Medtronic End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.12.4 Medtronic End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.12.5 Medtronic Key News

7.13 Sanxin Medtec

7.13.1 Sanxin Medtec Corporate Summary

7.13.2 Sanxin Medtec Business Overview

7.13.3 Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.13.4 Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.13.5 Sanxin Medtec Key News

7.14 Jafron Biomedical

7.14.1 Jafron Biomedical Corporate Summary

7.14.2 Jafron Biomedical Business Overview

7.14.3 Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.14.4 Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.14.5 Jafron Biomedical Key News

7.15 SWS Hemodialysis Care

7.15.1 SWS Hemodialysis Care Corporate Summary

7.15.2 SWS Hemodialysis Care Business Overview

7.15.3 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.15.4 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.15.5 SWS Hemodialysis Care Key News

7.16 Tianyi Medical

7.16.1 Tianyi Medical Corporate Summary

7.16.2 Tianyi Medical Business Overview

7.16.3 Tianyi Medical End Stage Renal Disease (ESRD) Therapy Major Product Offerings

7.16.4 Tianyi Medical End Stage Renal Disease (ESRD) Therapy Revenue in Global Market (2017-2022)

7.16.5 Tianyi Medical Key News

8 Conclusion

9 Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

List of Tables

Table 1. End Stage Renal Disease (ESRD) Therapy Market Opportunities & Trends in Global Market

Table 2. End Stage Renal Disease (ESRD) Therapy Market Drivers in Global Market

Table 3. End Stage Renal Disease (ESRD) Therapy Market Restraints in Global Market

Table 4. Key Players of End Stage Renal Disease (ESRD) Therapy in Global Market

Table 5. Top End Stage Renal Disease (ESRD) Therapy Players in Global Market, Ranking by Revenue (2021)

Table 6. Global End Stage Renal Disease (ESRD) Therapy Revenue by Companies, (US$, Mn), 2017-2022

Table 7. Global End Stage Renal Disease (ESRD) Therapy Revenue Share by Companies, 2017-2022

Table 8. Global Companies End Stage Renal Disease (ESRD) Therapy Product Type

Table 9. List of Global Tier 1 End Stage Renal Disease (ESRD) Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 End Stage Renal Disease (ESRD) Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - End Stage Renal Disease (ESRD) Therapy Revenue in Global (US$, Mn), 2017-2022

Table 13. By Type - End Stage Renal Disease (ESRD) Therapy Revenue in Global (US$, Mn), 2023-2028

Table 14. By Application – Global End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2021 & 2028

Table 15. By Application - End Stage Renal Disease (ESRD) Therapy Revenue in Global (US$, Mn), 2017-2022

Table 16. By Application - End Stage Renal Disease (ESRD) Therapy Revenue in Global (US$, Mn), 2023-2028

Table 17. By Region – Global End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2021 & 2028

Table 18. By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), 2017-2022

Table 19. By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), 2023-2028

Table 20. By Country - North America End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2022

Table 21. By Country - North America End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2023-2028

Table 22. By Country - Europe End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2022

Table 23. By Country - Europe End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2023-2028

Table 24. By Region - Asia End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2022

Table 25. By Region - Asia End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2023-2028

Table 26. By Country - South America End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2022

Table 27. By Country - South America End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2023-2028

Table 28. By Country - Middle East & Africa End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2022

Table 29. By Country - Middle East & Africa End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2023-2028

Table 30. Fresenius Corporate Summary

Table 31. Fresenius End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 32. Fresenius End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 33. DaVita Corporate Summary

Table 34. DaVita End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 35. DaVita End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 36. Baxter Corporate Summary

Table 37. Baxter End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 38. Baxter End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 39. Nipro Corporate Summary

Table 40. Nipro End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 41. Nipro End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 42. B. Braun Corporate Summary

Table 43. B. Braun End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 44. B. Braun End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 45. Asahi Kasei Corporate Summary

Table 46. Asahi Kasei End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 47. Asahi Kasei End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 48. Nikkiso Corporate Summary

Table 49. Nikkiso End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 50. Nikkiso End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 51. WEGO Corporate Summary

Table 52. WEGO End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 53. WEGO End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 54. Newsol Corporate Summary

Table 55. Newsol End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 56. Newsol End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 57. Mayo Clinic Corporate Summary

Table 58. Mayo Clinic End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 59. Mayo Clinic End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 60. Guangdong Biolight Corporate Summary

Table 61. Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 62. Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 63. Medtronic Corporate Summary

Table 64. Medtronic End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 65. Medtronic End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 66. Sanxin Medtec Corporate Summary

Table 67. Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 68. Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 69. Jafron Biomedical Corporate Summary

Table 70. Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 71. Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 72. SWS Hemodialysis Care Corporate Summary

Table 73. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 74. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

Table 75. Tianyi Medical Corporate Summary

Table 76. Tianyi Medical End Stage Renal Disease (ESRD) Therapy Product Offerings

Table 77. Tianyi Medical End Stage Renal Disease (ESRD) Therapy Revenue (US$, Mn), (2017-2022)

List of Figures

Figure 1. End Stage Renal Disease (ESRD) Therapy Segment by Type in 2021

Figure 2. End Stage Renal Disease (ESRD) Therapy Segment by Application in 2021

Figure 3. Global End Stage Renal Disease (ESRD) Therapy Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global End Stage Renal Disease (ESRD) Therapy Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global End Stage Renal Disease (ESRD) Therapy Revenue, 2017-2028 (US$, Mn)

Figure 7. The Top 3 and 5 Players Market Share by End Stage Renal Disease (ESRD) Therapy Revenue in 2021

Figure 8. By Type - Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 9. By Application - Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 10. By Region - Global End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 11. By Country - North America End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 12. US End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 13. Canada End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 14. Mexico End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 15. By Country - Europe End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 16. Germany End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 17. France End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 18. U.K. End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 19. Italy End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 20. Russia End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 21. Nordic Countries End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 22. Benelux End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 23. By Region - Asia End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 24. China End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 25. Japan End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 26. South Korea End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 27. Southeast Asia End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 28. India End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 29. By Country - South America End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 30. Brazil End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 31. Argentina End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 32. By Country - Middle East & Africa End Stage Renal Disease (ESRD) Therapy Revenue Market Share, 2017-2028

Figure 33. Turkey End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 34. Israel End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 35. Saudi Arabia End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 36. UAE End Stage Renal Disease (ESRD) Therapy Revenue, (US$, Mn), 2017-2028

Figure 37. Fresenius End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 38. DaVita End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 39. Baxter End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 40. Nipro End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 41. B. Braun End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 42. Asahi Kasei End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 43. Nikkiso End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 44. WEGO End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 45. Newsol End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 46. Mayo Clinic End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 47. Guangdong Biolight End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 48. Medtronic End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 49. Sanxin Medtec End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 50. Jafron Biomedical End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 51. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 52. Tianyi Medical End Stage Renal Disease (ESRD) Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)